Skip to main content

Advertisement

Log in

ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells

  • Original Article
  • Published:
Tumor Biology

Abstract

Zinc and ring finger 3 (ZNRF3) is a transmembrane E3 ubiquitin ligase that has emerged as an important regulator of cancer development; however, its cancer-related function remains controversial. Here, we investigated the possible role of ZNRF3 in thyroid carcinoma (TC). We found that ZNRF3 is downregulated in papillary thyroid carcinoma (PTC) compared to normal thyroid tissues and inversely correlated with the degree of cell differentiation. Overexpression of ZNRF3 significantly suppressed cell malignant behaviors, including cell proliferation, migration, and invasion in vitro, as well as tumor growth in vivo. Consistent with recent studies showing that ZNRF3 is involved in the Wnt/β-catenin pathway, ZNRF3 overexpression negatively regulated β-catenin activation, modulating PTC cell behaviors. Clinical specimens revealed a significant inverse correlation between ZNRF3 and β-catenin mRNA levels. Taken together, these results provide insight into a potential tumor suppressor role of ZNRF3 in PTC progression, and may have potential clinical relevance for the prognosis and treatment of PTC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.

    Article  CAS  PubMed  Google Scholar 

  2. Min XS, Peng H, Xu L, Chao D, Jiang XL, Yuan ZT, et al. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma. Tumor Biol. 2015;36:1–7.

    Article  Google Scholar 

  3. Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7:569–80.

    Article  CAS  PubMed  Google Scholar 

  4. Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery. 2009;145:176–81.

    Article  PubMed  Google Scholar 

  5. Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, et al. Znrf3 promotes wnt receptor turnover in an r-spondin-sensitive manner. Nature. 2012;485:195–200.

    Article  CAS  PubMed  Google Scholar 

  6. Zhou Y, Lan J, Wang W, Shi Q, Lan Y, Cheng Z, et al. Znrf3 acts as a tumour suppressor by the wnt signalling pathway in human gastric adenocarcinoma. J Mol Histol. 2013;44:555–63.

    Article  CAS  PubMed  Google Scholar 

  7. Yagyu R, Furukawa Y, Lin YM, Shimokawa T, Yamamura T, Nakamura Y. A novel oncoprotein rnf43 functions in an autocrine manner in colorectal cancer. Int J Oncol. 2004;25:1343–8.

    CAS  PubMed  Google Scholar 

  8. Shinada K, Tsukiyama T, Sho T, Okumura F, Asaka M, Hatakeyama S. Rnf43 interacts with nedl1 and regulates p53-mediated transcription. Biochem Biophys Res Commun. 2011;404:143–7.

    Article  CAS  PubMed  Google Scholar 

  9. Cooper CL, O’Toole SA, Kench JG. Classification, morphology and molecular pathology of premalignant lesions of the pancreas. Pathology. 2013;45:286–304.

    Article  CAS  PubMed  Google Scholar 

  10. Koo B-K, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M, et al. Tumour suppressor rnf43 is a stem-cell e3 ligase that induces endocytosis of wnt receptors. Nature. 2012;488:665–9.

    Article  CAS  PubMed  Google Scholar 

  11. Peng WC, de Lau W, Madoori PK, Forneris F, Granneman JC, Clevers H, et al. Structures of wnt-antagonist znrf3 and its complex with r-spondin 1 and implications for signaling. PLoS One. 2013;8:e83110.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zebisch M, Jones EY. Znrf3/rnf43—a direct linkage of extracellular recognition and e3 ligase activity to modulate cell surface signalling. Prog Biophys Mol Biol. 2015;118:112–8.

  13. Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang X, et al. Mir-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting znrf3. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2015;35:71–82.

    Article  CAS  Google Scholar 

  14. Shi J, Jiang X, Yu Z, He G, Ning H, Wu Z, et al. Znrf3 contributes to the growth of lung carcinoma via inhibiting wnt/beta-catenin pathway and is regulated by mir-93. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015.

  15. Xing C, Zhou W, Ding S, Xie H, Zhang W, Yang Z, et al. Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma. Mol Cancer Ther. 2013;12:94–103.

    Article  CAS  PubMed  Google Scholar 

  16. Jiang X, Hao HX, Growney JD, Woolfenden S, Bottiglio C, Ng N, et al. Inactivating mutations of rnf43 confer wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A. 2013;110:12649–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad. 2011;108:21188–93.

    Article  CAS  Google Scholar 

  18. Reid MD, Saka B, Balci S, Goldblum AS, Adsay NV. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications. Am J Clin Pathol. 2014;141:168–80.

    Article  CAS  PubMed  Google Scholar 

  19. Zou Y, Wang F, Liu FY, Huang MZ, Li W, Yuan XQ, et al. Rnf43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer. Gene. 2013;531:112–6.

    Article  CAS  PubMed  Google Scholar 

  20. Uchida N, Tsunoda T, Wada S, Furukawa Y, Nakamura Y, Tahara H. Ring finger protein 43 as a new target for cancer immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004;10:8577–86.

    Article  CAS  Google Scholar 

  21. Hazama S, Nakamura Y, Takenouchi H, Suzuki N, Tsunedomi R, Inoue Y, et al. A phase i study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. J Transl Med. 2014;12:63.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sakamoto H, Kuboki Y, Hatori T, Yamamoto M, Sugiyama M, Shibata N, et al. Clinicopathological significance of somatic rnf43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas. 2014. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc.

    Google Scholar 

  23. Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE, et al. Rnf43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol. 2013;229:469–76.

    Article  CAS  PubMed  Google Scholar 

  24. Amato E, Molin MD, Mafficini A, Yu J, Malleo G, Rusev B, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014;233:217–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192–205.

    Article  CAS  PubMed  Google Scholar 

  26. Gencer S, Sen G, Dogusoy G, Belli AK, Paksoy M, Yazicioglu MB. Beta-catenin-independent noncanonical wnt pathway might be induced in gastric cancers. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2010;21:224–30.

    Article  Google Scholar 

  27. Kanth VVR, Bhalsing S, Sasikala M, Rao GV, Pradeep R, Avanthi US, et al. Microsatellite instability and promoter hypermethylation in colorectal cancer in India. Tumor Biol. 2014;35:4347–55.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This project was supported by the National Natural Science Foundation of China (No. 81272935). Furthermore, we are grateful to the Thyroid and Parathyroid Center of Shanghai Jiaotong University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qi Zheng.

Ethics declarations

Conflicts of interests

None

Additional information

Wangwang Qiu and Zhili Yang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiu, W., Yang, Z., Fan, Y. et al. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells. Tumor Biol. 37, 12665–12672 (2016). https://doi.org/10.1007/s13277-016-5250-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-5250-4

Keywords

Navigation